Stock Events

Stock Events

Entheon Biomedical 

$0.07
2
-$0.01-8.86% Thursday 21:00

Statistics

Day High
0.07
Day Low
0.07
52W High
0.12
52W Low
0.05
Volume
100
Avg. Volume
67
Mkt Cap
997,776
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31AugExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-0.05
-0.03
-0.01
0.01
Expected EPS
N/A
Actual EPS
0.006

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-464,943.02Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ENTBF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap606.35M
Compass Pathways operates in the psychedelic medicine sector, focusing on psilocybin therapy for depression, similar to Entheon's focus on psychedelic therapies.
AtaiBeckley
ATAI
Mkt Cap1.56B
ATAI Life Sciences is a biotech company developing psychedelic and non-psychedelic compounds for mental health disorders, overlapping with Entheon's market.
GH Research
GHRS
Mkt Cap888.26M
GH Research focuses on developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment space.
Cybin Inc
CYBN
Mkt Cap200.49M
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, directly competing with Entheon's business model in mental health.
Revive Therapeutics
RVVTF
Mkt Cap4.68M
Revive Therapeutics explores psilocybin-based therapies, which is a direct competition to Entheon's psychedelic research and development.
Noveris Health Sciences
MYCOF
Mkt Cap14.59M
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, competing in the same niche as Entheon.

About

Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Timothy Ko
Country
CA
ISIN
CA29383X2023

Listings

F
DE
1XU.F
CN
CA
ENBI.CN
OTC Link
US
ENTBF

0 Comments

Share your thoughts

FAQ

What is Entheon Biomedical stock price today?▼
The current price of ENTBF is $0.07 USD — it has decreased by -8.86% in the past 24 hours. Watch Entheon Biomedical stock price performance more closely on the chart.
What is Entheon Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Entheon Biomedical stocks are traded under the ticker ENTBF.
Is Entheon Biomedical stock price growing?▼
ENTBF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Entheon Biomedical has showed a -41.61% decrease.
What is Entheon Biomedical market cap?▼
Today Entheon Biomedical has the market capitalization of 997,776
What were Entheon Biomedical earnings last quarter?▼
ENTBF earnings for the last quarter are 0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Entheon Biomedical revenue for the last year?▼
Entheon Biomedical revenue for the last year amounts to 0 USD.
What is Entheon Biomedical net income for the last year?▼
ENTBF net income for the last year is -464,943.02 USD.
In which sector is Entheon Biomedical located?▼
Entheon Biomedical operates in the Health Care sector.
When did Entheon Biomedical complete a stock split?▼
The last stock split for Entheon Biomedical was on March 01, 2024 with a ratio of 1:10.
Where is Entheon Biomedical headquartered?▼
Entheon Biomedical is headquartered in Vancouver, CA.